carbamates and incb-018424

carbamates has been researched along with incb-018424 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Miyamoto, T; Yoshimoto, G	1
Bardini, M; Biondi, A; Bugarin, C; Cazzaniga, G; Davis, KL; Fazio, G; Fossati, G; Gaipa, G; Izraeli, S; Meyer, LH; Nolan, GP; Palmi, C; Sarno, J; Savino, AM; Te Kronnie, G; Trentin, L; Vieri, M	1
Gong, Y; Qi, F; Zhang, J; Zhou, S; Zhu, B	1

Reviews

2 review(s) available for carbamates and incb-018424

Article	Year
[Treatment strategy for myeloproliferative neoplasms]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10 Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential	2014
Biological Therapies for Atopic Dermatitis: A Systematic Review. Dermatology (Basel, Switzerland), 2021, Volume: 237, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; Biological Products; Carbamates; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Heterocyclic Compounds, 3-Ring; Humans; Nitriles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides	2021

Article

Year

[Treatment strategy for myeloproliferative neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential

2014

Biological Therapies for Atopic Dermatitis: A Systematic Review.

Dermatology (Basel, Switzerland), 2021, Volume: 237, Issue:4

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; Biological Products; Carbamates; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Heterocyclic Compounds, 3-Ring; Humans; Nitriles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides

2021

Other Studies

1 other study(ies) available for carbamates and incb-018424

Article	Year
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL. Leukemia, 2017, Volume: 31, Issue:11 Topics: Adolescent; Animals; Carbamates; Cell Line, Tumor; Child, Preschool; Female; Histone Deacetylase Inhibitors; Humans; Male; Mice; Nitriles; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Receptors, Cytokine; STAT5 Transcription Factor; Xenograft Model Antitumor Assays	2017

Article

Year

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Leukemia, 2017, Volume: 31, Issue:11

Topics: Adolescent; Animals; Carbamates; Cell Line, Tumor; Child, Preschool; Female; Histone Deacetylase Inhibitors; Humans; Male; Mice; Nitriles; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Receptors, Cytokine; STAT5 Transcription Factor; Xenograft Model Antitumor Assays

2017